(Q48380991)

11 February 2018

review article

1 reference

title

The importance of inflammatory mechanisms in Alzheimer disease. (English)

1 reference

11 February 2018

0 references

0 references

McGeer EG

1

1 reference

11 February 2018

McGeer PL

series ordinal

2

1 reference

11 February 2018

publication date

1 August 1998

1 reference

11 February 2018

published in

Experimental Gerontology

1 reference

11 February 2018

volume

33

1 reference

11 February 2018

page(s)

371-378

1 reference

11 February 2018

issue

5

1 reference

11 February 2018

Inverse association of anti-inflammatory treatments and Alzheimer's disease: initial results of a co-twin control study.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2898%2900013-8

7 January 2021

Delayed onset of Alzheimer's disease with nonsteroidal anti-inflammatory and histamine H2 blocking drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2898%2900013-8

7 January 2021

NSAIDs and cognition in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2898%2900013-8

7 January 2021

Prevention of NSAID-induced gastric ulcer with misoprostol: multicentre, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2898%2900013-8

7 January 2021

Rheumatoid arthritis and senile dementia of the Alzheimer's type.

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2898%2900013-8

7 January 2021

Activation of macrophages by Alzheimer beta amyloid peptide.

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2898%2900013-8

7 January 2021

The role of the immune system in neurodegenerative disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2898%2900013-8

7 January 2021

The future use of complement inhibitors for the treatment of neurological diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2898%2900013-8

7 January 2021

The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2898%2900013-8

7 January 2021

Anti‐inflammatory agents as a therapeutic approach to Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2898%2900013-8

7 January 2021

Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2898%2900013-8

7 January 2021

Physiology and pathophysiology of complement: progress and trends.

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2898%2900013-8

7 January 2021

Nonsteroidal anti-inflammatory drugs in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2898%2900013-8

7 January 2021

Clinical trial of indomethacin in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2898%2900013-8

7 January 2021

Apolipoprotein E alleles as risk factors in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2898%2900013-8

7 January 2021

Hippocampal damage associated with prolonged glucocorticoid exposure in primates

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2898%2900013-8

7 January 2021

Neuronal expression of mRNAs for complement proteins of the classical pathway in Alzheimer brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2898%2900013-8

7 January 2021

Risk of Alzheimer's disease and duration of NSAID use.

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2898%2900013-8

7 January 2021

Chromogranin A triggers a phenotypic transformation and the generation of nitric oxide in brain microglial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2898%2900013-8

7 January 2021

Neurons express proteins of the classical complement pathway in Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2898%2900013-8

7 January 2021

Molecular and cellular characterization of the membrane attack complex, C5b-9, in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2898%2900013-8

7 January 2021

10.1016/S0531-5565(98)00013-8

Identifiers

DOI

1 reference

11 February 2018

PubMed ID

9762518

1 reference

11 February 2018